Stock Search
Search for you Ticker
Find and analyze stocks with comprehensive financial metrics including P/E ratios, dividend yields, and growth indicators. Filter by sector, valuation metrics, and performance to identify investment opportunities.
Company Overview
GILEAD SCIENCES, INC.
Health CareBiotechnologyGilead Sciences, Inc. () is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas...
Gilead Sciences, Inc. () is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
The company has faced criticism over its business practices, including extremely high pricing of drugs such as Sovaldi and Truvada in the United States relative to production cost and cost in the developing world.
Exchange: Nasdaq
Company Statistics
Profile
Market Cap$190.89B
EV$213.95B
Shares Out1.2B
Revenue$30.46B
Margins
Gross79.6%
Operating-8.2%
Pre-Tax-6.4%
Net-10.6%
FCF42.5%
Returns (5Yr Avg)
ROA8.1%
ROE24.4%
ROCE14.3%
ROIC14.7%
Valuation (TTM)
P/E-58.9
P/B16.1
EV/Sales7.0
P/FCF14.7
EV/Gross Profit8.8
Financial Health
Cash$3.18B
Net Debt$23.07B
Debt/Equity2.2
Growth (CAGR)
Rev 3Yr2.6%
Rev 5Yr3.6%
Rev 10Yr-1%
Dil EPS 3Yr23%
Dil EPS 5Yr1.3%
Dil EPS 10Yr-5.5%
FCF 5Yr4.7%
Shares 5Yr-0.1%
Dividends
Yield2.1%
Payout-1.2%
DPS$3.25
DPS Growth 3Yr-6.4%
DPS Growth 5Yr-2.8%
DPS Growth 10Yr2.9%
Price History
No price history available
Financial Performance
Display:
Data reported in USD
Assets vs Liabilities
Data reported in USD
Free Cash Flow
Data reported in USD